From breakthrough drug discovery to next-gen clinical trials, AI and ML are driving unprecedented change across the life sciences industry. But what’s coming in 2025? In this must-read article, IQVIA’s Alison Sloane joins fellow industry experts to share her predictions on how AI will shape healthcare innovation in the year ahead. Read the full article here: https://bit.ly/4icl41U #AIinHealthcare #LifeSciences #HealthTech
IQVIA Safety & Regulatory Compliance
Hospitals and Health Care
Danbury and Durham, Connecticut and North Carolina 20,808 followers
End-to-end integrated tech services and analytics solutions for safety, regulatory, quality and commercial compliance
About us
IQVIA has a vision that goes beyond simply optimizing individual safety, regulatory, quality, and compliance functions. Using cloud-based technology combined with advanced analytics—including artificial intelligence and machine learning—IQVIA is bringing together global regulatory intelligence, safety data, product quality information and legal/ethical guidance on an integrated platform. For customers, this means: • Improved compliance performance at lower cost across all functions • Visibility across their complete compliance landscape • Faster response times • More predictive planning, throughout the product lifecycle Learn more are: www.iqvia.com/GlobalCompliance
- Website
-
https://www.iqvia.com/GlobalCompliance
External link for IQVIA Safety & Regulatory Compliance
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Danbury and Durham, Connecticut and North Carolina
- Specialties
- commercial compliance, safety compliance, regulatory compliance, quality compliance, and compliance
Updates
-
How can AI help you stay compliant with evolving FDA guidelines? Join IQVIA’s experts for this on-demand webinar as we explore the integration of AI into pharmacovigilance processes – improving safety, efficiency, and compliance. Featuring IQVIA’s Patrick Brady, Archana Hegde, and Updesh Dosanjh, expect to gain actionable insights and strategies to position your organization as a leader in PV innovation. Watch now: https://bit.ly/4kaPGT8 #AIInPharma #Pharmacovigilance #FDACompliance
-
-
Don't miss this new IQVIA white paper that examines the FDA's initiatives toward encouraging earlier oncology studies via Project FrontRunner, offering practical regulatory guidance on engaging with the FDA and leveraging accelerated approval pathways to expedite patient access to new therapies.
What if patients could access life-saving treatments sooner? In the battle against cancer, every second counts. Dive into our latest white paper, where IQVIA's experts reveal how the FDA’s Project FrontRunner is reshaping oncology care and provide expert guidance to accelerate breakthroughs. Read the insights in full: https://lnkd.in/dKbHjEnF #CancerTreatment #DrugDevelopment #ProjectFrontRunner
-
Cutting pharmacovigilance costs by 50%? This is IQVIA’s AI vision in action! Imagine combining superhuman accuracy with streamlined processes to revolutionize drug safety. In this exclusive interview, IQVIA’s Uwe Trinks unveils how AI is transforming pharmacovigilance – reducing costs, and improving outcomes across the board. Read the full interview here, and uncover the future of pharma innovation... https://bit.ly/4ibJSaj #AIPoweredPV #PharmaInnovation #DrugSafety
-
-
Learn valuable safety insights from Ana Pedro Jesuíno in IQVIA's "2025 SRC Trends and Predictions White Paper." Discover how AI is revolutionizing pharmacovigilance with increased automation and integration, enhancing data collection and reporting accuracy. Learn about the role of local Qualified Persons for Pharmacovigilance (QPPVs) in ensuring compliance across regions and the importance of partnering with competent vendors. Download now to discover key findings: https://bit.ly/3EZ8SD3 #QPPV #AI #Pharmacovigilance #LQPPV
-
-
From intelligent chatbots to self-service portals, AI is transforming how healthcare providers and patients access critical information. By handling routine queries, these innovations take the pressure off medical information teams – freeing time to focus on more meaningful, high-value interactions. Discover how AI is reshaping the MI landscape in this fascinating piece from IQVIA’s Simon Johns: https://bit.ly/3XePhoP #AIinHealthcare #MedicalInformation #DigitalHealth
-
-
As we enter a new era for global regulatory compliance, IQVIA’s Marcela Miño considers the impact of AI on compliance within lifecycle maintenance (LCM). Despite a traditionally reactionary approach, AI is set to drive the industry towards a more proactive future – allowing organizations to anticipate regulatory shifts, optimize the decision-making process, and enhance global agility. Read these insights in full in Contract Pharma: https://bit.ly/436BDI1 #AIinRegulatory #PharmaCompliance #LifecycleManagement
-
-
Regulations and standards mandate key activities, but approaches vary based on market route, product risk class, and therapeutic area. A modular, scalable eQMS enhances operational effectiveness. Connect with us to discuss optimizing your processes and eQMS solutions with IQVIA Technologies. https://bit.ly/4b6puVJ #eQMSsolutions #regulatorycompliance #operationalexcellence
-
-
As the pharmaceutical industry continues to experience an explosion of data – due to the growth of new therapies, drugs, devices, and data sources – your safety organization must rethink its approach to automation. IQVIA’s Updesh Dosanjh explores how our Safety Automation Maturity Matrix (SAMM) can help you to keep pace, streamline safety surveillance, and address issues with rapidity. https://bit.ly/3EULSVO #SafetyAutomation
-
-
What if drug safety checks could be done in a day instead of a week? With up to 95% accuracy and costs set to drop by 50% by 2027, GenAI is shaping the future of pharmacovigilance for faster approvals, safer outcomes, and smarter processes. Ready to transform how you think about drug safety? Dive into Uwe Trinks’ insights here: https://bit.ly/4hHE6gx #Pharmacovigilance #GenAI #DrugSafety
-